Life Science Compliance Update

« Previous article | Home| Next article »

June 28, 2017

An FCA Journey - Allergan to Pay $53M to DOJ

Allergan Logo_02

Allergan has been hit with hefty fines over the past several months. This article outlines Allergan's alleged wrongdoing, and the settlement amount agreed to by the government and Allergan. 

The Life Science industry is no stranger to sales representatives as whistleblowers. Nor is the industry a stranger to claims of “sham” educational programs as disguised kickbacks to prescribers. Allergan (formerly Forest Laboratories) early in 2017 became the first in a long line of companies to settle claims with both the U.S. Department of Justice (“DOJ”) and Securities and Exchange Commission (“SEC”) – albeit on different issues.

To Read the Full Story, Subscribe, Download a Sample Issue, or Sign In

« Previous article | Home| Next article »


Feed You can follow this conversation by subscribing to the comment feed for this post.

Verify your Comment

Previewing your Comment

This is only a preview. Your comment has not yet been posted.

Your comment could not be posted. Error type:
Your comment has been saved. Comments are moderated and will not appear until approved by the author. Post another comment

The letters and numbers you entered did not match the image. Please try again.

As a final step before posting your comment, enter the letters and numbers you see in the image below. This prevents automated programs from posting comments.

Having trouble reading this image? View an alternate.


Post a comment

Comments are moderated, and will not appear until the author has approved them.


Preview | Powered by FeedBlitz


December 2017
Sun Mon Tue Wed Thu Fri Sat
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30